These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 10338262)
1. The overactive bladder: an overview for primary care health providers. Wein AJ; Rovner ES Int J Fertil Womens Med; 1999; 44(2):56-66. PubMed ID: 10338262 [TBL] [Abstract][Full Text] [Related]
2. Evaluation and treatment of the overactive bladder. Rovner ES; Gomes CM; Trigo-Rocha FE; Arap S; Wein AJ Rev Hosp Clin Fac Med Sao Paulo; 2002; 57(1):39-48. PubMed ID: 12170348 [TBL] [Abstract][Full Text] [Related]
4. Defining overactive bladder: epidemiology and burden of disease. Tubaro A Urology; 2004 Dec; 64(6 Suppl 1):2-6. PubMed ID: 15621220 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and burden of overactive bladder in the United States. Stewart WF; Van Rooyen JB; Cundiff GW; Abrams P; Herzog AR; Corey R; Hunt TL; Wein AJ World J Urol; 2003 May; 20(6):327-36. PubMed ID: 12811491 [TBL] [Abstract][Full Text] [Related]
6. Solifenacin for overactive bladder with incontinence: symptom bother and health-related quality of life outcomes. Garely AD; Lucente V; Vapnek J; Smith N Ann Pharmacother; 2007 Mar; 41(3):391-8. PubMed ID: 17341526 [TBL] [Abstract][Full Text] [Related]
7. Reversing the tide: emerging options for treating overactive bladder symptoms in women. Lemack GE Tex Med; 1999 Nov; 95(11):78-81. PubMed ID: 10578627 [TBL] [Abstract][Full Text] [Related]
8. Overactive bladder: treatment options in primary care medicine. Sussman DO J Am Osteopath Assoc; 2007 Sep; 107(9):379-85. PubMed ID: 17908830 [TBL] [Abstract][Full Text] [Related]
10. Overactive bladder--a practical approach to evaluation and management. Madersbacher H J Med Liban; 2004; 52(4):220-6. PubMed ID: 16432986 [TBL] [Abstract][Full Text] [Related]
11. The wet patient: understanding patients with overactive bladder and incontinence. Serels S Curr Med Res Opin; 2004 Jun; 20(6):791-801. PubMed ID: 15200735 [TBL] [Abstract][Full Text] [Related]
12. The overactive bladder: Epidemiology and morbidity. Tyagi S; Thomas CA; Hayashi Y; Chancellor MB Urol Clin North Am; 2006 Nov; 33(4):433-8, vii. PubMed ID: 17011378 [TBL] [Abstract][Full Text] [Related]
15. Family pediatrics: report of the Task Force on the Family. Schor EL; Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595 [TBL] [Abstract][Full Text] [Related]
16. Overactive bladder in women: symptom impact and treatment expectations. MacDiarmid S; Rosenberg M Curr Med Res Opin; 2005 Sep; 21(9):1413-21. PubMed ID: 16197660 [TBL] [Abstract][Full Text] [Related]
17. Symptom bother and health-related quality of life outcomes following solifenacin treatment for overactive bladder: the VESIcare Open-Label Trial (VOLT). Garely AD; Kaufman JM; Sand PK; Smith N; Andoh M Clin Ther; 2006 Nov; 28(11):1935-46. PubMed ID: 17213014 [TBL] [Abstract][Full Text] [Related]
18. Urodynamic classification of patients with symptoms of overactive bladder. Flisser AJ; Walmsley K; Blaivas JG J Urol; 2003 Feb; 169(2):529-33; discussion 533-4. PubMed ID: 12544302 [TBL] [Abstract][Full Text] [Related]
19. The causes and consequences of overactive bladder. Miller J; Hoffman E J Womens Health (Larchmt); 2006 Apr; 15(3):251-60. PubMed ID: 16620184 [TBL] [Abstract][Full Text] [Related]
20. Office management of geriatric urinary incontinence. Gibbs CF; Johnson TM; Ouslander JG Am J Med; 2007 Mar; 120(3):211-20. PubMed ID: 17349439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]